Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Accumulated Depreciation: 2022-2024

Historic Accumulated Depreciation for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $1.3 million.

  • Orchestra BioMed Holdings' Accumulated Depreciation rose 26.99% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 26.99%. This contributed to the annual value of $1.3 million for FY2024, which is 24.81% up from last year.
  • Orchestra BioMed Holdings' Accumulated Depreciation amounted to $1.3 million in FY2024, which was up 24.81% from $1.0 million recorded in FY2023.
  • Orchestra BioMed Holdings' Accumulated Depreciation's 5-year high stood at $1.3 million during FY2024, with a 5-year trough of $778,000 in FY2022.
  • In the last 3 years, Orchestra BioMed Holdings' Accumulated Depreciation had a median value of $1.0 million in 2023 and averaged $1.0 million.
  • Data for Orchestra BioMed Holdings' Accumulated Depreciation shows a peak YoY spiked of 34.19% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Accumulated Depreciation stood at $778,000 in 2022, then soared by 34.19% to $1.0 million in 2023, then increased by 24.81% to $1.3 million in 2024.